Management of end stage cardiac failure
- 1 June 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 83 (980) , 395-401
Abstract
Optimum heart failure medication and an increasing array of interventions have had an enormous effect on morbidity and mortality over the past 10 years. However, patients with end stage disease can still be highly symptomatic. Moreover, such patients are disadvantaged compared with patients with malignant disease. They are less likely to have an understanding of their illness or have access to supportive care. They are also less likely to have the opportunity to plan for care with regard to death and dying. There is increasing demand that the multi-professional clinical team gain good communication and supportive care skills, and that appropriate access to specialist palliative care services is available.Keywords
This publication has 69 references indexed in Scilit:
- Inadequate nutritional intake for daily life activity of clinically stable patients with chronic heart failureThe American Journal of Cardiology, 2004
- Mirtazapine for PruritusJournal of Pain and Symptom Management, 2003
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Do general practice patients with heart failure understand its nature and seriousness, and want improved information?Patient Education and Counseling, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Case studies outlining use of nebulized morphine for patients with end-stage chronic lung and cardiac diseaseJournal of Pain and Symptom Management, 1993
- Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failureThe Lancet, 1992
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987